Related Experiment Video

Updated: May 20, 2025

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

17.7K

PTEN: a new dawn in Parkinson's disease treatment

Xinghuang Yang1, Tianqi Liu1, Hong Cheng2

  • 1Medical College, Yangzhou University, Yangzhou, China.

Frontiers in Cellular Neuroscience
|March 25, 2025
PubMed

Insights

Phosphatase and tension homolog (PTEN) is linked to Parkinson's disease (PD) pathogenesis. Understanding PTEN's regulatory roles, including phosphorylation and ubiquitination, offers new therapeutic targets for this neurodegenerative disorder.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Oncology

Background:

  • Phosphatase and tension homolog (PTEN) is a well-established tumor suppressor, extensively studied in cancer.
  • Parkinson's disease (PD) is a complex neurodegenerative disorder with incompletely understood etiology.
  • Emerging research suggests a significant link between PTEN and the pathogenesis of PD.

Purpose of the Study:

  • To elucidate the multifaceted roles of PTEN in Parkinson's disease.
  • To explore PTEN's regulatory mechanisms, including post-translational modifications and molecular interactions, in the context of PD.
  • To identify PTEN as a potential therapeutic target for PD.

Main Methods:

  • Review of existing literature on PTEN function and its involvement in PD.
  • Analysis of regulatory pathways affecting PTEN, such as phosphorylation, ubiquitination, RNA molecules, and exosomes.
  • Investigation of transcriptional regulation, chemical modification, and PTEN subtype variations relevant to PD.

Main Results:

  • PTEN plays a crucial role in the development and progression of Parkinson's disease.
  • Multiple regulatory mechanisms, including phosphorylation, ubiquitination, and non-coding RNAs, modulate PTEN's function in PD.
  • PTEN's involvement extends beyond its known oncogenic functions to neurodegeneration.

Conclusions:

  • PTEN is implicated in the pathogenesis of Parkinson's disease through various regulatory pathways.
  • Further research into PTEN's mechanisms in PD is warranted.
  • PTEN presents a promising therapeutic target for novel drug development in Parkinson's disease treatment.
Keywords:
PTENParkinson’s diseaseclinical therapeuticspathologysignaling pathway

More Related Videos

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

54.9K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

6.7K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
166
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
118
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K